Ayman Rabayah
☆    

Jordan,
2020-04-08 13:23
(1471 d 08:22 ago)

Posting: # 21318
Views: 1,249
 

 Tegaserod analytical method [Regulatives / Guidelines]

Post reply
Hello colleagues
I hope you are in good health and conditions, and wish the the COVID-19 crisis come to end in all countries.
kindly we are developing an analytical method for Tegaserod in human plasma, if you have an experience with this product (6 mg dose), is the metabolite M29 need to be included to be detected and measured, and if an LLOQ of 50 pg/ml will be enough?

looking to hear your advises
Thank you
 
UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,669 registered users;
50 visitors (0 registered, 50 guests [including 3 identified bots]).
Forum time: 21:46 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5